Do you want to read an article? Please log in or register.
A prospective multicentre study of intravitreal injections and ocular surface in 219 patients: IVIS study
Further Publications
Related content
COMMENTED
Retinal Diseases
Multicentre study of 4626 patients assesses the effectiveness, safety and burden of two categories of treatments for central retinal vein occlusion: intravitreal anti-vascular endothelial growth factor injections and intravitreal Ozurdex injections
★ 2
Recommended and commented by
Dr habil. Gábor Márk Somfai, PhD, Faculty Member
Br J Ophthalmol
Gale R, Gill C, Pikoula M, Lee AY, Hanson RLW, Denaxas S, Egan C, Tufail A, Taylor P, UK EMR Database Users Group.
doi: 10.1136/bjophthalmol-2020-317306
Surgery and Intervention
Association of Intravitreal Injections With Blood Pressure Increase: The Following Excitement and Anxiety Response Under Intravitreal Injection Study
JAMA Ophthalmol.
Berger V, Munk MR, Lersch F, Wolf S, Ebneter A, Zinkernagel MS
doi: 10.1001/jamaophthalmol.
Macular Diseases
Dexamethasone intravitreal implant in treatment-naïve diabetic macular oedema: findings from the prospective, multicentre, AUSSIEDEX study
Br J Ophthalmol
Fraser-Bell S, Kang HK, Mitchell P, Arnold JJ, Tainton J, Simonyi S
doi: 10.1136/bjophthalmol-2021-319070
Glaucoma and Ocular PressureMacular DiseasesOcular Oncology
Intravitreal Anti-VEGF Injections Reduce Aqueous Outflow Facility in Patients With Neovascular Age-Related Macular Degeneration
Invest Ophthalmol Vis Sci.
Wen JC, Reina-Torres E, Sherwood JM, Challa P, Liu KC, Li G, Chang JY, Cousins SW, Schuman SG, Mettu PS, Stamer WD, Overby DR, Allingham RR
doi: 10.1167/iovs.16-20786.
Retinal Diseases
Loss to Follow-Up in Patients with Proliferative Diabetic Retinopathy after Panretinal Photocoagulation or Intravitreal Anti-VEGF Injections
Ophthalmology.
Obeid A, Gao X, Ali FS, Talcott KE, Aderman CM, Hyman L, Ho AC, Hsu J
doi: 10.1016/j.ophtha.
COMMENTED
Association of Acute Endophthalmitis With Intravitreal Injections of Corticosteroids or Anti-Vascular Growth Factor Agents in a Nationwide Study in France
JAMA Ophthalmol.
Baudin F, Benzenine E, Mariet AS, Bron AM, Daien V, Korobelnik JF, Quantin C, Creuzot-Garcher C
doi: 10.1001/
Macular Diseases
AFLIBERCEPT AFTER RANIBIZUMAB INTRAVITREAL INJECTIONS IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION: The ARI2 Study
Retina.
Blanco-Garavito R, Jung C, Uzzan J, Quaranta-ElMaftouhi M, Coscas F, Sahel J, Korobelnik JF, Béchet S, Querques G, Souied EH
doi: 10.1097/IAE.
Retinal Diseases
Photodynamic therapy in combination with intravitreal ziv-aflibercept and aflibercept injection in patients with chronic or repeatedly recurrent acute central serous chorioretinopathy: a single-center retrospective study
Clin Ophthalmol.
Doepfner JM, Michels S, Graf N, Becker MD, Freiberg FJ
doi: 10.2147/OPTH.S165199.
Macular Diseases
Vision-Related Quality of Life in Patients with Diabetic Macular Edema Treated with Intravitreal Aflibercept: The AQUA Study
Ophthalmol Retina.
Garweg JG, Stefanickova J, Hoyng C, Schmelter T, Niesen T, Sowade O, Sivaprasad S, AQUA Investigators.
doi: 10.1016/j.oret.2019.03.012.